Aptevo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.

About APVO

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.

CEO

Marvin L. White

CEOMarvin L. White

Employees

Employees40

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2016

Founded2016

Employees

Employees40

APVO Key Statistics

Market cap

3.61M

Market cap3.61M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

3.72M

Average volume3.72M

High today

$0.974

High today$0.974

Low today

$0.88

Low today$0.88

Open price

$0.94

Open price$0.94

Volume

188.43K

Volume188.43K

52 Week high

$80.96

52 Week high$80.96

52 Week low

$0.67

52 Week low$0.67

APVO News

Yahoo Finance 5d

Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update - Yahoo Finance

Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after entering the ALG.APV-527...